{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:26:13Z","timestamp":1788351973352,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan plc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s13555-019-00322-5","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T08:03:23Z","timestamp":1568189003000},"page":"725-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Erythema of Rosacea Affects Health-Related Quality of Life: Results of a Survey Conducted in Collaboration with the National Rosacea Society"],"prefix":"10.1007","volume":"9","author":[{"given":"Hilary E.","family":"Baldwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"key":"322_CR1","first-page":"282","volume":"179","author":"L Gether","year":"2018","unstructured":"Gether L, Overgaard LK, Egeberg A, Thyssen JP. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 2018;179:282\u20139.","journal-title":"Br J Dermatol"},{"key":"322_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/jdv.13556","volume":"30","author":"J Tan","year":"2016","unstructured":"Tan J, Schofer H, Araviiskaia E, Audibert F, Kerrouche N, Berg M. Prevalence of rosacea in the general population of Germany and Russia\u2014the RISE study. J Eur Acad Dermatol Venereol. 2016;30:428\u201334.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"322_CR3","first-page":"725","volume":"11","author":"HE Baldwin","year":"2012","unstructured":"Baldwin HE. Diagnosis and treatment of rosacea: state of the art. J Drugs Dermatol. 2012;11:725\u201330.","journal-title":"J Drugs Dermatol"},{"key":"322_CR4","first-page":"234","volume":"92","author":"JQ Del Rosso","year":"2013","unstructured":"Del Rosso JQ, Thiboutot D, Gallo R, et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care. Cutis. 2013;92:234\u201340.","journal-title":"Cutis"},{"key":"322_CR5","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.jaad.2013.04.043","volume":"69","author":"J Tan","year":"2013","unstructured":"Tan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol. 2013;69:S27\u201335.","journal-title":"J Am Acad Dermatol"},{"key":"322_CR6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/cpp.763","volume":"19","author":"D Su","year":"2012","unstructured":"Su D, Drummond PD. Blushing propensity and psychological distress in people with rosacea. Clin Psychol Psychother. 2012;19:488\u201395.","journal-title":"Clin Psychol Psychother"},{"key":"322_CR7","unstructured":"National Rosacea Society. Coping with rosacea. 2016. http:\/\/www.rosacea.org\/patients\/materials\/coping\/managing.php#Managing. Accessed 29 Mar 2016."},{"key":"322_CR8","first-page":"348","volume":"6","author":"TT Huynh","year":"2013","unstructured":"Huynh TT. Burden of disease: the psychosocial impact of rosacea on a patient\u2019s quality of life. Am Health Drug Benefits. 2013;6:348\u201354.","journal-title":"Am Health Drug Benefits"},{"key":"322_CR9","first-page":"47","volume":"11","author":"JA Zeichner","year":"2018","unstructured":"Zeichner JA, Eichenfield LF, Feldman SR, Kasteler JS, Ferrusi IL. Quality of life in individuals with erythematotelangiectatic and papulopustular rosacea: findings from a web-based survey. J Clin Aesth Dermatol. 2018;11:47\u201352.","journal-title":"J Clin Aesth Dermatol"},{"key":"322_CR10","first-page":"17","volume":"10","author":"JQ Del Rosso","year":"2017","unstructured":"Del Rosso JQ, Tanghetti EA, Baldwin HE, Rodriguez DA, Ferrusi IL. The burden of illness of erythematotelangiectatic rosacea and papulopustular rosacea: findings from a web-based survey. J Clin Aesth Dermatol. 2017;10:17\u201331.","journal-title":"J Clin Aesth Dermatol"},{"key":"322_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/archderm.1988.01670060015008","volume":"124","author":"TB Fitzpatrick","year":"1988","unstructured":"Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869\u201371.","journal-title":"Arch Dermatol"},{"key":"322_CR12","first-page":"AB99","volume":"76","author":"IL Ferrusi","year":"2017","unstructured":"Ferrusi IL, Ahluwalia G, Andrae DA. Development and validation of the symptom assessment for rosacea facial redness (SA-RFR) [abstract 5677]. J Am Acad Dermatol. 2017;76:AB99.","journal-title":"J Am Acad Dermatol"},{"key":"322_CR13","first-page":"A160","volume":"20","author":"IL Ferrusi","year":"2017","unstructured":"Ferrusi IL, Ahluwalia G, Andrae DA. Patient-rated impact assessment for rosacea facial redness (IA-RFR): results of two phase 3 pivotal trials of oxymetazoline cream 1% vs vehicle [abstract PSS26]. Value Health. 2017;20:A160.","journal-title":"Value Health"},{"key":"322_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"322_CR15","first-page":"997","volume":"159","author":"MK Basra","year":"2008","unstructured":"Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159:997\u20131035.","journal-title":"Br J Dermatol"},{"key":"322_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","volume":"125","author":"Y Hongbo","year":"2005","unstructured":"Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean? J Invest Dermatol. 2005;125:659\u201364.","journal-title":"J Invest Dermatol"},{"key":"322_CR17","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1080\/13548506.2013.841968","volume":"19","author":"D Bohm","year":"2014","unstructured":"Bohm D, Schwanitz P, Stock GS, Schmid-Ott G, Schulz W. Symptom severity and psychological sequelae in rosacea: results of a survey. Psychol Health Med. 2014;19:586\u201391.","journal-title":"Psychol Health Med"},{"key":"322_CR18","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1468-3083.2012.04549.x","volume":"27","author":"FC Beikert","year":"2013","unstructured":"Beikert FC, Langenbruch AK, Radtke MA, Augustin M. Willingness to pay and quality of life in patients with rosacea. J Eur Acad Dermatol Venereol. 2013;27:734\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"322_CR19","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1365-2133.2010.09894.x","volume":"163","author":"B Aksoy","year":"2010","unstructured":"Aksoy B, Altaykan-Hapa A, Egemen D, Karagoz F, Atakan N. The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol. 2010;163:719\u201325.","journal-title":"Br J Dermatol"},{"key":"322_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/13548506.2017.1361540","volume":"23","author":"Y Wu","year":"2018","unstructured":"Wu Y, Fu C, Zhang W, Li C, Zhang J. The Dermatology Life Quality Index (DLQI) and the hospital anxiety and depression (HADS) in Chinese rosacea patients. Psychol Health Med. 2018;23:369\u201374.","journal-title":"Psychol Health Med"},{"key":"322_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/000155500750012153","volume":"80","author":"R Zachariae","year":"2000","unstructured":"Zachariae R, Zachariae C, Ibsen H, Mortensen JT, Wulf HC. Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol. 2000;80:272\u20136.","journal-title":"Acta Derm Venereol"},{"key":"322_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2340\/00015555-1920","volume":"95","author":"E Parna","year":"2015","unstructured":"Parna E, Aluoja A, Kingo K. Quality of life and emotional state in chronic skin disease. Acta Derm Venereol. 2015;95:312\u20136.","journal-title":"Acta Derm Venereol"},{"key":"322_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/jdv.13757","volume":"31","author":"C Richter","year":"2017","unstructured":"Richter C, Trojahn C, Hillmann K, et al. Sensitivity to change of the Dermatology Life Quality Index in adult females with facial acne vulgaris: a validation study. J Eur Acad Dermatol Venereol. 2017;31:169\u201374.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"322_CR24","doi-asserted-by":"publisher","first-page":"7224","DOI":"10.19082\/7224","volume":"10","author":"MS Alanazi","year":"2018","unstructured":"Alanazi MS, Hammad SM, Mohamed AE. Prevalence and psychological impact of Acne vulgaris among female secondary school students in Arar city, Saudi Arabia, in 2018. Electron Phys. 2018;10:7224\u20139.","journal-title":"Electron Phys"},{"key":"322_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s13555-016-0106-9","volume":"6","author":"A Bewley","year":"2016","unstructured":"Bewley A, Fowler J, Schofer H, Kerrouche N, Rives V. Erythema of rosacea impairs health-related quality of life: results of a meta-analysis. Dermatol Ther (Heidelb). 2016;6:237\u201347.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"322_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1600-0536.2012.02062.x","volume":"67","author":"D Boehm","year":"2012","unstructured":"Boehm D, Schmid-Ott G, Finkeldey F, et al. Anxiety, depression and impaired health-related quality of life in patients with occupational hand eczema. Contact Dermat. 2012;67:184\u201392.","journal-title":"Contact Dermat"},{"key":"322_CR27","first-page":"32","volume":"22","author":"R Ghaderi","year":"2014","unstructured":"Ghaderi R, Saadatjoo A. Quality of life in patients with hand eczema as health promotion: a case control study. Acta Dermatovenerol Croat. 2014;22:32\u20139.","journal-title":"Acta Dermatovenerol Croat"},{"key":"322_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/cod.12130","volume":"70","author":"PA Cortesi","year":"2014","unstructured":"Cortesi PA, Scalone L, Belisari A, et al. Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids. Contact Dermat. 2014;70:158\u201368.","journal-title":"Contact Dermat"},{"key":"322_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/cod.12067","volume":"69","author":"M Lindberg","year":"2013","unstructured":"Lindberg M, Bingefors K, Meding B, Berg M. Hand eczema and health-related quality of life; a comparison of EQ-5D and the Dermatology Life Quality Index (DLQI) in relation to the Hand Eczema Extent Score (HEES). Contact Dermatitis. 2013;69:138\u201343.","journal-title":"Contact Dermatitis"},{"key":"322_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00403-013-1402-1","volume":"306","author":"FC Beikert","year":"2014","unstructured":"Beikert FC, Langenbruch AK, Radtke MA, Kornek T, Purwins S, Augustin M. Willingness to pay and quality of life in patients with atopic dermatitis. Arch Dermatol Res. 2014;306:279\u201386.","journal-title":"Arch Dermatol Res"},{"key":"322_CR31","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3346\/jkms.2012.27.11.1327","volume":"27","author":"DH Kim","year":"2012","unstructured":"Kim DH, Li K, Seo SJ, et al. Quality of life and disease severity are correlated in patients with atopic dermatitis. J Korean Med Sci. 2012;27:1327\u201332.","journal-title":"J Korean Med Sci"},{"key":"322_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000104263","volume":"215","author":"L Misery","year":"2007","unstructured":"Misery L, Finlay AY, Martin N, et al. Atopic dermatitis: impact on the quality of life of patients and their partners. Dermatology. 2007;215:123\u20139.","journal-title":"Dermatology"},{"key":"322_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1550-8579(04)80017-2","volume":"1","author":"EA Holm","year":"2004","unstructured":"Holm EA, Esmann S, Jemec GB. Does visible atopic dermatitis affect quality of life more in women than in men? Gend Med. 2004;1:125\u201330.","journal-title":"Gend Med"},{"key":"322_CR34","first-page":"153","volume":"18","author":"M Moradi","year":"2015","unstructured":"Moradi M, Rencz F, Brodszky V, Moradi A, Balogh O, Gulacsi L. Health status and quality of life in patients with psoriasis: an Iranian cross-sectional survey. Arch Iran Med. 2015;18:153\u20139.","journal-title":"Arch Iran Med"},{"key":"322_CR35","first-page":"151","volume":"18","author":"T Palotai","year":"2010","unstructured":"Palotai T, Szepietowski JC, Pec J, et al. A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe. Acta Dermatovenerol Croat. 2010;18:151\u201361.","journal-title":"Acta Dermatovenerol Croat"},{"key":"322_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1610-0387.2007.06240.x","volume":"5","author":"O Schoffski","year":"2007","unstructured":"Schoffski O, Augustin M, Prinz J, et al. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study. J Dtsch Dermatol Ges. 2007;5:209\u201318.","journal-title":"J Dtsch Dermatol Ges"},{"key":"322_CR37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jaad.2014.03.039","volume":"71","author":"E Martinez-Garcia","year":"2014","unstructured":"Martinez-Garcia E, Arias-Santiago S, Valenzuela-Salas I, Garrido-Colmenero C, Garcia-Mellado V, Buendia-Eisman A. Quality of life in persons living with psoriasis patients. J Am Acad Dermatol. 2014;71:302\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"322_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1684\/ejd.2014.2511","volume":"25","author":"H Cakmur","year":"2015","unstructured":"Cakmur H, Dervis E. The relationship between quality of life and the severity of psoriasis in Turkey. Eur J Dermatol. 2015;25:169\u201376.","journal-title":"Eur J Dermatol"},{"key":"322_CR39","doi-asserted-by":"publisher","first-page":"4371471","DOI":"10.1155\/2018\/4371471","volume":"2018","author":"A Mohd Affandi","year":"2018","unstructured":"Mohd Affandi A, Khan I, Ngah Saaya N. Epidemiology and clinical features of adult patients with psoriasis in Malaysia: 10-year review from the Malaysian Psoriasis Registry (2007\u20132016). Dermatol Res Pract. 2018;2018:4371471.","journal-title":"Dermatol Res Pract"},{"key":"322_CR40","unstructured":"Ryan CL, Bauman K. Educational attainment in the United States: 2015. https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2016\/demo\/p20-578.pdf. Accessed 12 Apr 2016."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-019-00322-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-019-00322-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-019-00322-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T16:14:35Z","timestamp":1710346475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-019-00322-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["322"],"URL":"https:\/\/doi.org\/10.1007\/s13555-019-00322-5","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]},"assertion":[{"value":"18 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}